Search

Pharma industry hits out at Horizon 2020 cut

Europe’s pharma industry says the €2.2B cut to Horizon 2020 is misguided, while scientists and MEPs declare themselves happy, for the most part, that the cut is less than the €2.7B originally proposed

Patents can make or break drug discovery in Poland

There are several barriers holding back science-industry collaboration, but the most urgent one is the reluctance to protect intellectual property in advance of publishing research results, according to two of Poland’s leading patent attorneys

The SME instrument: tips & tricks for greater success

Since its 2014 launch the SME instrument has attracted applications from across Europe. But the quality is low, with only 12% passing the quality threshold. Bernd Reichert, head of unit at the Executive Agency for SMEs, offers tips for success

ESOF 2016: Call for Science to Business Programme Sessions

The Science to Business Programme is a fundamental component of ESOF 2016 and will provide opportunities for industrialists, researchers, policy makers and business/academia support organisations to engage with one another, learn, network and debate the issues surrounding the exploitation of breakthroughs in science and share ideas and best practise for improving the commercial outcomes from research.

University of Pisa unveils new bionic hand

Researchers behind a robotic hand designed by the University of Pisa’s “E. Piaggio” research centre in collaboration with the Istituto Italiano di Tecnologia want to revolutionise the way we think about artificial limbs. Simple and robust in structure, and cheaper than previous technologies, the new ‘Softhand’ is capable of reproducing almost all natural hand movements